J3387
HCPCSInj elivaldogene autotemecel
Official HCPCS Level II long descriptor
Injection, elivaldogene autotemcel, per treatment
HCPCS Level II code J3387 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj elivaldogene autotemecel
Added to HCPCS: 2026-01-01
Nearby codes in J3
- J3373Inj, vancomycin hcl, 10 mg
- J3374Inj, vancomycin (mylan) 10mg
- J3375Inj, vanco (tyzavan) 10mg
- J3376Inj vancomycin (hikma) 10mg
- J3379Inj, valproate sod, 5 mg
- J3380Inj vedolizumab iv 1 mg
- J3385Velaglucerase alfa
- J3386Etuvetidigene autotemecel
- J3389Topi adm prad zami per treat
- J3391Inj, atidarsagene autotemcel
- J3392Inj, exagamglogene autotem
- J3393Inj, betibeglogene autotemce
- J3394Inj, lovotibeglogene autotem
- J3396Verteporfin injection
- J3397Inj., vestronidase alfa-vjbk
- J3398Inj luxturna 1 billion vec g
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.